These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

992 related items for PubMed ID: 19101233

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.
    Nishii M, Inomata T, Takehana H, Naruke T, Yanagisawa T, Moriguchi M, Takeda S, Izumi T.
    J Am Coll Cardiol; 2008 Jun 17; 51(24):2329-35. PubMed ID: 18549918
    [Abstract] [Full Text] [Related]

  • 3. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R, Pousset F, Chafirovskaïa O, Carayon A, Hulot JS, Thomas D, Komajda M.
    Am Heart J; 2003 Oct 17; 146(4):729-35. PubMed ID: 14564330
    [Abstract] [Full Text] [Related]

  • 4. B-type natriuretic peptide can predict the medium-term risk in patients with acute heart failure and preserved systolic function.
    Valle R, Aspromonte N, Feola M, Milli M, Canali C, Giovinazzo P, Carbonieri E, Ceci V, Cerisano S, Barro S, Milani L.
    J Card Fail; 2005 Sep 17; 11(7):498-503. PubMed ID: 16198244
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P, Valle R, Aspromonte N, D'Aloia A, Di Tano G, Barro S, Giovinazzo P, Milani L, Lorusso R, Dei Cas L.
    Int J Cardiol; 2010 Apr 01; 140(1):88-94. PubMed ID: 19321212
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy.
    Schenk S, McCarthy PM, Starling RC, Hoercher KJ, Hail MD, Ootaki Y, Francis GS, Doi K, Young JB, Fukamachi K.
    J Thorac Cardiovasc Surg; 2004 Jul 01; 128(1):38-43. PubMed ID: 15224019
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Prognostic value of BNP and cardiopulmonary exercise testing in patients with systolic heart failure on beta-blocker therapy].
    Pascual-Figal DA, Peñafiel P, Nicolas F, de la Morena G, Ansaldo P, Redondo B, Sánchez Mas J, Valdés M.
    Rev Esp Cardiol; 2008 Mar 01; 61(3):260-8. PubMed ID: 18361899
    [Abstract] [Full Text] [Related]

  • 13. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M, Aspromonte N, Milani L, Bobbio M, Bardellotto S, Barro S, Giovinazzo P, Noventa F, Valle R.
    J Card Fail; 2008 Jun 01; 14(5):420-5. PubMed ID: 18514935
    [Abstract] [Full Text] [Related]

  • 14. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 15. Heart-type fatty acid binding protein is a novel prognostic marker in patients with non-ischaemic dilated cardiomyopathy.
    Komamura K, Sasaki T, Hanatani A, Kim J, Hashimura K, Ishida Y, Ohkaru Y, Asayama K, Tanaka T, Ogai A, Nakatani T, Kitamura S, Kangawa K, Miyatake K, Kitakaze M.
    Heart; 2006 May 15; 92(5):615-8. PubMed ID: 16387818
    [Abstract] [Full Text] [Related]

  • 16. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 May 15; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 17. Relation of B-type natriuretic peptide levels before and after exercise and functional capacity in patients with idiopathic dilated cardiomyopathy.
    Pascual-Figal DA, Peñafiel P, de la Morena G, Redondo B, Nicolás F, Casas T, Valdés M.
    Am J Cardiol; 2007 May 01; 99(9):1279-83. PubMed ID: 17478157
    [Abstract] [Full Text] [Related]

  • 18. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S, Huelsmann M, Strunk G, Stoiser B, Struck J, Morgenthaler NG, Bergmann A, Moertl D, Berger R, Pacher R.
    J Am Coll Cardiol; 2008 Jul 22; 52(4):266-72. PubMed ID: 18634981
    [Abstract] [Full Text] [Related]

  • 19. Clinical course and risk profile in adolescents with idiopathic dilated cardiomyopathy.
    Limongelli G, Pacileo G, Ancona R, Eusebio G, D'Andrea A, Romano M, Di Salvo G, Rea A, Calabró P, Romano G, Maiello C, Calabró R.
    Am J Cardiol; 2010 Mar 01; 105(5):716-20. PubMed ID: 20185022
    [Abstract] [Full Text] [Related]

  • 20. Multiparametric risk stratification in patients with mild to moderate chronic heart failure.
    Scardovi AB, De Maria R, Coletta C, Aspromonte N, Perna S, Cacciatore G, Parolini M, Ricci R, Ceci V.
    J Card Fail; 2007 Aug 01; 13(6):445-51. PubMed ID: 17675058
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.